Status:
COMPLETED
Platelet Rich Plasma (PRP) One-Shot Injection For Supraspinatus Tendinosis
Lead Sponsor:
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Conditions:
Supraspinatus Tendinitis
Eligibility:
All Genders
18+ years
Brief Summary
It was conducted a prospective study with a series of 50 patients treated with PRP one-shot injection in patient affected by Supraspinatus Tendinosis. One independent observer performed clinical and f...
Eligibility Criteria
Inclusion
- Age \> 18 years old;
- Supraspinatus tendinosis detected by MRI.
Exclusion
- Supraspinatus rupture;
- Previous shoulder surgery;
- Rotator cuff tears secondary to fracture;
- Hemoglobin \<7 g/dL or Platelets \< 30,000 microL;
- Active infection;
- Pregnant patients;
- Patients with hematologic and oncologic diseases.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04851951
Start Date
January 1 2018
End Date
April 1 2021
Last Update
April 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOUC Policlinico di Bari - UOC Ortopedia e Traumatologia
Bari, Italy, 70124